{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:57:35Z","timestamp":1792785455898,"version":"4.5.0"},"reference-count":200,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China","award":["32571118"],"award-info":[{"award-number":["32571118"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/14760584.2026.2746121","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:18:10Z","timestamp":1791976690000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Virus-like particle vaccines: from antigen architecture to antigen presentation and adaptive immune responses"],"prefix":"10.1080","volume":"25","author":[{"given":"Zihan","family":"Zhang","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Zheng","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Kunming, China"]},{"name":"Chinese Academy of Medical Sciences","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longding","family":"Liu","sequence":"additional","affiliation":[{"name":"Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Kunming, China"]},{"name":"Chinese Academy of Medical Sciences","place":["Kunming, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2508517"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00479-7"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200737984"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8248784"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01597-9"},{"key":"e_1_3_5_8_1","unstructured":"World Health Organization. Cecolin [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/extranet.who.int\/prequal\/vaccines\/p\/cecolinr"},{"key":"e_1_3_5_9_1","unstructured":"Xinhua. China approves first domestically developed 9-valent HPV vaccine [Internet]. 2025 [cited 2026 Sep 13]. Available from: https:\/\/english.www.gov.cn\/news\/202506\/04\/content_WS68403587c6d0868f4e8f312e.html"},{"key":"e_1_3_5_10_1","unstructured":"World Health Organization. Considerations for human papillomavirus (HPV) vaccine product choice [Internet]. 2024 [cited 2026 Sep 13]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240100930"},{"key":"e_1_3_5_11_1","unstructured":"U.S. Food and Drug Administration. GARDASIL 9 [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/gardasil-9"},{"key":"e_1_3_5_12_1","unstructured":"U.S. Food and Drug Administration. Hepatitis B vaccine (recombinant) [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/hepatitis-b-vaccine-recombinant"},{"key":"e_1_3_5_13_1","unstructured":"World Health Organization. Hepatitis E [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-e"},{"key":"e_1_3_5_14_1","unstructured":"U.S. Food and Drug Administration. Package insert - Recombivax HB [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/media\/74274\/download"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00449-16"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01088-09"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-016-0181-1"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06415-8"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adx6291"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44869-0"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07814-1"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20654-7"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-024-01655-9"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2025.2511132"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00391-8"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200535068"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7587"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.9.5346"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3405"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjp001"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1501637"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-026-04349-7"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9111236"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.6b00532"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-021-00330-7"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.04.011"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701067"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12834"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11020479"},{"key":"e_1_3_5_40_1","unstructured":"U.S. Food and Drug Administration. ENGERIX-B [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/engerix-b"},{"key":"e_1_3_5_41_1","unstructured":"U.S. Food and Drug Administration. Package insert: ENGERIX-B [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/media\/119403\/download?attachment="},{"key":"e_1_3_5_42_1","unstructured":"European Medicines Agency. HBVaxPro [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/hbvaxpro"},{"key":"e_1_3_5_43_1","unstructured":"European Medicines Agency. HBVaxPro: product information [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/hbvaxpro-epar-product-information_en.pdf"},{"key":"e_1_3_5_44_1","unstructured":"U.S. Food and Drug Administration. HEPLISAV-B [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/heplisav-b"},{"key":"e_1_3_5_45_1","unstructured":"U.S. Food and Drug Administration. Package insert: HEPLISAV-B [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/media\/108745\/download"},{"key":"e_1_3_5_46_1","unstructured":"European Medicines Agency. Fendrix [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/fendrix"},{"key":"e_1_3_5_47_1","unstructured":"European Medicines Agency. Fendrix: scientific discussion [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-discussion\/fendrix-epar-scientific-discussion_en.pdf"},{"key":"e_1_3_5_48_1","unstructured":"U.S. Food and Drug Administration. PREHEVBRIO [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/prehevbrio"},{"key":"e_1_3_5_49_1","unstructured":"U.S. Food and Drug Administration. Package insert: PREHEVBRIO [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/media\/154561\/download"},{"key":"e_1_3_5_50_1","unstructured":"U.S. Food and Drug Administration. Clinical review memo: PREHEVBRIO [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/media\/154807\/download"},{"key":"e_1_3_5_51_1","unstructured":"Israel Ministry of Health. Discontinuation of use of Sci-B-Vac hepatitis B vaccine [Hebrew] [Internet]. 2024 [cited 2026 Sep 13]. Available from: https:\/\/www.gov.il\/BlobFolder\/policy\/hb\/he\/files_publications_units_epidemiology_epi-693630924.pdf"},{"key":"e_1_3_5_52_1","unstructured":"European Medicines Agency. Cervarix [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/cervarix"},{"key":"e_1_3_5_53_1","unstructured":"Centers for Disease Control and Prevention. HPV vaccine safety and effectiveness data [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.cdc.gov\/hpv\/hcp\/vaccination-considerations\/safety-and-effectiveness-data.html"},{"key":"e_1_3_5_54_1","unstructured":"U.S. Food and Drug Administration. GARDASIL [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/gardasil"},{"key":"e_1_3_5_55_1","unstructured":"World Health Organization. Walrinvax [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/extranet.who.int\/prequal\/vaccines\/p\/walrinvaxr"},{"key":"e_1_3_5_56_1","unstructured":"Indonesian Food and Drug Authority. Vaceta: public assessment report [Indonesian] [Internet]. 2024 [cited 2026 Sep 13]. Available from: https:\/\/registrasiobat.pom.go.id\/files\/assesment-reports\/14259424111736732785.pdf"},{"key":"e_1_3_5_57_1","unstructured":"Central Drugs Standard Control Organisation. CERVAVAC: summary of product characteristics [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/cdsco.gov.in\/opencms\/resources\/UploadCDSCOWeb\/2018\/UploadSmPC\/qHPV%20-%20SmPC%202022.pdf"},{"key":"e_1_3_5_58_1","unstructured":"Nanolek. Nanolek received a registration certificate for the first Russian vaccine against human papillomavirus [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/nanolek.ru\/en\/news\/companynews\/nanolek-received-a-registration-certificate-for-the-first-russian-vaccine-against-human-papillomavirus\/"},{"key":"e_1_3_5_59_1","unstructured":"Xiamen Innovax Biotech Co. Ltd. Cecolin 9: recombinant human papillomavirus 9-valent vaccine (Escherichia coli) [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.xiameninnovax.com\/professional\/cecolin-9-hpv-9-valent-vaccine\/"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.05.064"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1008870"},{"key":"e_1_3_5_62_1","unstructured":"European Medicines Agency. Mosquirix: summary of positive opinion [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/outside-eu-smop-initial\/chmp-summary-positive-opinion-mosquirix_en.pdf"},{"key":"e_1_3_5_63_1","unstructured":"World Health Organization. Mosquirix: product information [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/extranet.who.int\/prequal\/sites\/default\/files\/vwa_vaccine\/FVP-P-424_Malaria_2dose_GSK_PI_2024.pdf"},{"key":"e_1_3_5_64_1","unstructured":"World Health Organization. WHO prequalifies a second malaria vaccine a significant milestone in prevention of the disease [Internet]. 2023 [cited 2026 Sep 13]. Available from: https:\/\/www.who.int\/news\/item\/21-12-2023-who-prequalifies-a-second-malaria-vaccine-a-significant-milestone-in-prevention-of-the-disease"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep46621"},{"key":"e_1_3_5_66_1","unstructured":"Health Canada. Medicago Covifenz COVID-19 vaccine [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.canada.ca\/en\/health-canada\/services\/drugs-health-products\/covid19-industry\/drugs-vaccines-treatments\/vaccines\/medicago.html"},{"key":"e_1_3_5_67_1","unstructured":"Health Canada. Covifenz: product information and market status [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/health-products.canada.ca\/dpd-bdpp\/search-fast-recherche-rapide?code=17659&lang=eng"},{"key":"e_1_3_5_68_1","unstructured":"Health Canada. Summary basis of decision: Covifenz [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/covid-vaccine.canada.ca\/info\/SBD00582-covifenz-en.html"},{"key":"e_1_3_5_69_1","unstructured":"U.S. Food and Drug Administration. VIMKUNYA [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vimkunya"},{"key":"e_1_3_5_70_1","unstructured":"U.S. Food and Drug Administration. Approval Letter - VIMKUNYA [Internet]. 2025 Feb 14 [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/media\/185478\/download"},{"key":"e_1_3_5_71_1","unstructured":"U.S. Food and Drug Administration. Package insert: VIMKUNYA [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/media\/185477\/download?attachment="},{"key":"e_1_3_5_72_1","unstructured":"U.S. Food and Drug Administration. Vaccines licensed for use in the United States [Internet]. [cited 2026 Sep 13]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/vaccines-licensed-use-united-states"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.24.12180"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.5c07472"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)61030-6"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003255"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3096"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007562"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-9-2281"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.58.3.884-892.1986"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adp1453"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/298347a0"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02741-06"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410x(92)90391-v"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2105"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002124"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-022-12280-8"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01432"},{"key":"e_1_3_5_89_1","unstructured":"GlaxoSmithKline. WHO grants prequalification to GSK\u2019s Mosquirix \u2013 the first and only approved malaria vaccine [Internet]. 2022 [cited 2026 Sep 13]. Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/who-grants-prequalification-to-gsk-s-mosquirix-the-first-and-only-approved-malaria-vaccine\/"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1669415"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.01.142"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169533"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-7903159\/v1"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.739837"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep25741"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1115485109"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201707623"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202009663"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.0c00928"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1021\/bc100367u"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1039\/d0sc01878c"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mie.2018.12.010"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2024.02.027"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202509419"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.103"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.047"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100780"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/bit.24907"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16639-1"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.049"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-020-0719-0"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202412294"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-54876-2"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cplett.2021.138336"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12257-022-0107-8"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2017.02.031"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01100"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.02.042"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.03.045"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01230-17"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri723"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2007.09.006"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.80559-0"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature01912"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.1038\/354392a0"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2023.101729"},{"key":"e_1_3_5_127_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065x.1999.tb01360.x"},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-5890(01)00069-4"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2010.161"},{"key":"e_1_3_5_130_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24129851"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01643"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-019-0111-y"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.08.012"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117332"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.05.036"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1711.2004.01291.x"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2004.05.025"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11262-017-1451-1"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.986350"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01811-07"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c07360"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093598"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-024-01208-4"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.3.1777"},{"key":"e_1_3_5_145_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01679"},{"key":"e_1_3_5_146_1","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202152447"},{"key":"e_1_3_5_147_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c01283"},{"key":"e_1_3_5_148_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5c16068"},{"key":"e_1_3_5_149_1","doi-asserted-by":"publisher","DOI":"10.4110\/in.2023.23.e4"},{"key":"e_1_3_5_150_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2021.01.012"},{"key":"e_1_3_5_151_1","doi-asserted-by":"publisher","DOI":"10.1111\/all.15091"},{"key":"e_1_3_5_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2025.126787"},{"key":"e_1_3_5_153_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-4"},{"key":"e_1_3_5_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.05.005"},{"key":"e_1_3_5_155_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.906275"},{"key":"e_1_3_5_156_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-8518-3-2"},{"key":"e_1_3_5_157_1","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70101"},{"key":"e_1_3_5_158_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01606-08"},{"key":"e_1_3_5_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2015.08.013"},{"key":"e_1_3_5_160_1","doi-asserted-by":"publisher","DOI":"10.1111\/hel.70058"},{"key":"e_1_3_5_161_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1625670"},{"key":"e_1_3_5_162_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abn6612"},{"key":"e_1_3_5_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2019.09.024"},{"key":"e_1_3_5_164_1","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s237182"},{"key":"e_1_3_5_165_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00624"},{"key":"e_1_3_5_166_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1246"},{"key":"e_1_3_5_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.004"},{"key":"e_1_3_5_168_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1178334"},{"key":"e_1_3_5_169_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01370-1"},{"key":"e_1_3_5_170_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28339"},{"key":"e_1_3_5_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/44385"},{"key":"e_1_3_5_172_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2745"},{"key":"e_1_3_5_173_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2744"},{"key":"e_1_3_5_174_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300954"},{"key":"e_1_3_5_175_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1561297"},{"key":"e_1_3_5_176_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2519857123"},{"key":"e_1_3_5_177_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1175870"},{"key":"e_1_3_5_178_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01926-6"},{"key":"e_1_3_5_179_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.03.027"},{"key":"e_1_3_5_180_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.03.024"},{"key":"e_1_3_5_181_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4919"},{"key":"e_1_3_5_182_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90095-7"},{"key":"e_1_3_5_183_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.4.2340"},{"key":"e_1_3_5_184_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091777"},{"key":"e_1_3_5_185_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3554"},{"key":"e_1_3_5_186_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.06.012"},{"key":"e_1_3_5_187_1","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO;2-J"},{"key":"e_1_3_5_188_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1601852"},{"key":"e_1_3_5_189_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730471"},{"key":"e_1_3_5_190_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103312"},{"key":"e_1_3_5_191_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1206970109"},{"key":"e_1_3_5_192_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.9b02834"},{"key":"e_1_3_5_193_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903949"},{"key":"e_1_3_5_194_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.827256"},{"key":"e_1_3_5_195_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041225"},{"key":"e_1_3_5_196_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsabm.1c00718"},{"key":"e_1_3_5_197_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2019798118"},{"key":"e_1_3_5_198_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1817304"},{"key":"e_1_3_5_199_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adv5572"},{"key":"e_1_3_5_200_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adr8382"},{"key":"e_1_3_5_201_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2409566122"},{"key":"e_1_3_5_202_1","unstructured":"World Health Organization. Recommendations to assure the quality safety and efficacy of recombinant human papillomavirus virus-like particle vaccines [internet]. WHO Technical Report Series No. 999 Annex 4. Geneva: World Health Organization; 2016[cited 2026 Sep 13]. Available from: https:\/\/www.who.int\/publications\/m\/item\/recombinant-hpv-like-particle-vaccines-annex-4-trs-no-999"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2746121","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14760584.2026.2746121","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2026.2746121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:18:33Z","timestamp":1791976713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2026.2746121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":200,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/14760584.2026.2746121"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2026.2746121","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2746121"}}